This stock will be big - the founder, Paul Hopper, is an expert in this area, he sold his Viralytics business to Merck for $400m + in 2018, he is currently involved with Imugene who have massive potential and his network and expertise in the area of Oncology and cancer therapeutics is extensive - they're early at the moment but this has HUGE upside potential and is a stock i will definitely be lumping in and forgetting about for the next couple of years as they develop the technology
CHIMERIC THERAPEUTICS (CHM), who else is jumping on this big train of revenue.??, page-7
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
-0.001(25.0%) |
Mkt cap ! $9.323M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.3¢ | $22.28K | 6.311M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 78 | 84735861 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 86304338 | 23 |
View Market Depth
| Last trade - 14.27pm 25/07/2025 (20 minute delay) ? |
| CHM (ASX) Chart |